Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns Genetics and Heredity, Tests (Medical), Breast Cancer, Ovarian Cancer
By HEATHER MURPHY from NYT Health https://nyti.ms/2VO7doD
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.